4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0002034056-25-000009
General Counsel sold 1,304 shares at an average $367.81 ($479,627)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kelley Shannon T · General Counsel
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-18 | Sale : show line 1 in the form 10b5-1 | −458 | $358.66 | $164,266 | 10,019 | D |
| 2025-08-18 | Sale : show line 2 in the form 10b5-1 | −126 | $369.64 | $46,575 | 9,893 | D |
| 2025-08-18 | Sale : show line 3 in the form 10b5-1 | −84 | $370.06 | $31,085 | 9,809 | D |
| 2025-08-18 | Sale : show line 4 in the form 10b5-1 | −84 | $371.35 | $31,193 | 9,725 | D |
| 2025-08-18 | Sale : show line 5 in the form 10b5-1 | −252 | $372.44 | $93,855 | 9,473 | D |
| 2025-08-18 | Sale : show line 6 in the form 10b5-1 | −68 | $374.13 | $25,441 | 9,405 | D |
| 2025-08-18 | Sale : show line 7 in the form 10b5-1 | −190 | $375.75 | $71,393 | 9,215 | D |
| 2025-08-18 | Sale : show line 8 in the form 10b5-1 | −42 | $376.62 | $15,818 | 9,173 | D |
| Open-market sales · 1,304 sh · avg $367.81 · $479,627 | ||||||
Loading xslF345X05/wk-form4_1755552828.xml…